Specialty Pharmacy News

Image description

Diplomat acquires Focus Rx

Focus Rx offers home infusion and specialty prescription management services, and its acquisition will strengthen Diplomat’s ability to deliver solutions for increasing infusion therapy demand, the company said.
 

Image description

Teva names new president, CEO

Kåre Schultz Schultz has had a nearly 30-year career in the pharmaceutical and healthcare industries, including a long stint at Novo Nordisk, where he eventually became COO. 

Image description

Value Drug acquires specialty pharmacy Restore Rx

With the acquisition, the company said it would expand the scope of Value Specialty Pharmacy’s business while retaining the current leadership and employees of Restore Rx — and its prime location near FedEx's Memphis hub. 

Image description

Gilead to acquire Kite Pharma

Among the potential treatments Gilead will acquire is Kite’s most advanced therapy candidate, axicabtagene ciloleucel (axi-cel), a cancer-fighting therapy expected to be the first to market to treat refractory aggressive non-Hodgkin lymphoma, with a Food and Drug Administration decision date of Nov. 29.